Immunotherapy Genetics 101

Internet Search Results

Immunotherapy for Cancer - NCI
Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. Learn about the types of immunotherapy and what you can expect during treatment.

Side Effects of Immunotherapy - NCI - National Cancer Institute
Immunotherapy side effects happen when the immune system that has been prompted to act against the cancer also acts against healthy cells and tissues in the body. Learn about the types of side effects that immunotherapy might cause and where to go for more information.

Imfinzi, Keytruda Approved for Some Endometrial Cancers
FDA has approved three new immunotherapy options, including pembrolizumab (Keytruda) and durvalumab (Imfinzi), with chemo for advanced endometrial cancer.

Immune Checkpoint Inhibitors - NCI - National Cancer Institute
Immune checkpoint inhibitors are a type of immunotherapy that block immune checkpoint proteins from binding with partner proteins. Learn about the cancers treated with checkpoint inhibitors and the side effects they may cause.

Definition of immunotherapy - NCI Dictionary of Cancer Terms
Immunotherapy uses the body’s immune system to fight cancer. This animation explains three types of immunotherapy used to treat cancer: nonspecific immune stimulation, T-cell transfer therapy, and immune checkpoint inhibitors.

AI Tool May Help Guide Use of Cancer Immunotherapy - NCI
A class of immunotherapy drugs called immune checkpoint inhibitors have proven transformative for people with some types of cancer. In a small number of patients with advanced forms of melanoma, lung cancer, and other tumor types, deposits of cancer scattered throughout their bodies simply melt away.

Immunotherapy Combo Approved for dMMR Colorectal Cancer
The Food and Drug Administration (FDA) has approved the combination of two immunotherapy drugs for the initial treatment of some people with advanced colorectal cancer.

CAR T Cells: Engineering Immune Cells to Treat Cancer - NCI
Just a decade or so ago, immunotherapy was considered an exciting new way to treat some people with very advanced forms of a few types of cancer. Today, it’s a cornerstone of cancer treatment. A form of immunotherapy that has generated tremendous excitement are CAR T-cell therapies.

Pembrolizumab improves outcomes in high-risk bladder cancer
Results from a large clinical trial show that treatment with an immunotherapy drug may nearly double the length of time people with high-risk muscle-invasive bladder cancer are cancer-free following surgical removal of the bladder.

T-cell Transfer Therapy - Immunotherapy - NCI
How does T-cell transfer therapy work against cancer? T-cell transfer therapy is a type of immunotherapy that makes your own immune cells better able to attack cancer. There are two main types of T-cell transfer therapy: tumor-infiltrating lymphocytes (or TIL) therapy and CAR T-cell therapy.

* Latest Genetics 101 News *

*** News Filter: "Immunotherapy"

Cellular protein FGD3 boosts breast cancer chemotherapy and immunotherapy, study finds  Medical Xpress
Intracellular Checkpoints for NK Cell Cancer Immunotherapy | Newswise  Newswise
SITC 2025: Macrophage-targeting CAR monocytes Improve Immunotherapy Outcomes in Breast Cancer  Onco'Zine
Wild-type KRAS activation drives evasion of interferon-mediated immunity and resistance to immunotherapy in hepatocellular carcinoma  Nature
Stage IV melanoma survivor: An immunotherapy clinical trial saved my life  MD Anderson Cancer Center
Leukogene Therapeutics Receives Strategic Funding from South Carolina Research Authority to Accelerate Development of Its Cancer Immunotherapy Pipeline  BioSpace
What if the COVID-19 vaccine could save cancer patients too?  The Japan Times
Surgery after immunotherapy boosts survival for liver cancer patients  Medical Xpress
Combination immunotherapy for rare cancers shows improved efficacy and survival rates  Medical Xpress
mRNA Covid shots may boost the effects of certain cancer treatments, study suggests  statnews.com
Study: A cellular protein, FGD3, boosts breast cancer chemotherapy, immunotherapy  Illinois News Bureau
Third Arc Bio and Adagene Partner to Address One of the Biggest Challenges in Solid Tumor Immunotherapy  Oncodaily
Reviewing Long-Term CLL Treatment With BTK Inhibitor Zanubrutinib  Targeted Oncology
Google Maps–Style View of Lung Cancer May Predict Immunotherapy Response  Oncology News Central
Breast Cancer Biomarker Predicts Efficacy of Chemo and Immunotherapy  Inside Precision Medicine